
å¥è·¡ã®ç¹å¹è¬ãã¬ãã«ããã«ãã®æéããèãããã°ããŒããªãºã ãšãã䟡å€èŠ³ã®æ¬æ«è»¢åã
ããã«ã¡ã¯ãå®åã§ãã
ãã€ãåŸç¶ãªããŸãŸã«ãnoteãããŠããŸãã
æ¬åœã«æè¡éçºã¯çŽ æŽããããæè¡ã«ãããµã³ã¹ãšã§ãåŒã¹ãæä»£ã«çªå ¥ããŠããŸãã
éåããããWillowã
éåãã€ã
ãããŠãã®HIVã«å¯Ÿããå¥è·¡ã®ç¹å¹è¬
ãã¬ãã«ããã«ã
æè¿æ¥æ¬åœã«ããŠæããã®ã¯ããªãŒã«ãã¡ãã£ã¢ã«ãããæ°èŠãªã³ã©ã€ã³ã¡ãã£ã¢ã«ããã
ããããã®å ¬å ±æ§ãå¿ããŠãèªåéã®éœåã®è¯ãæ å ±ãæ£æçã«çºä¿¡ããŠãããã®ãã€ã³ãã«ãšã³ãµãŒãªã©ã䜿çšãããªãã©ãŒãã«å ãã å ±ææ§ãäœãåºããŠããæ§ãªæ°ãããŠããŸãã
ãã®ãã¬ãã«ããã«ãããWillowãã¯ééããªãéå»ã®ããŒãã«è³åè³è ç ç©¶ããè¶ è¶ãã倧çºèŠã§ãã£ãŠã
ããããã®åžžèãæ ¹åºããèŠããŠããã§ãããã
æ¬æ¥ã¯ãã¹ã¡ãã£ã¢ã«ãããSNSã€ã³ãã«ãšã³ãµãŒã¡ãã£ã¢ã«ããããããã®ãã¥ãŒã¹ã«æ¥ã
è³ãã£ãŠããŠç¶ãã¹ããªã®ã«
ãããå°ããªãã¥ãŒã¹ã«æººããŠããŠããã
äžå± ãããããç³ç Žèããããããã©ã³ããšæ¯ã¹ãŠã倧åãªæ å ±ã¯ããããããã
ãã®äžã§æŽåãèµ·ãããã瀟äŒå šäœã¯å¹³åã«èŠããæ¥ã ãçæŒ ç¶ãšç¹°ãè¿ããŠãããéãå µåšãååšããŠããªããã€ãªãã¶ãŒãã®äžçã«äœããŸã³ãã®ããã§ãå°ãææããæããŸãã
ããŠããã¬ãã«ããã«ãã«ã€ããŠã
HIVæ²»çã«ãããŠã100ïŒ ãã®äºé²æäžè¬ã宿ããã
ãšãã話ã§ãã
ã€ãŸãããããå
šäººé¡ãæäžããã°ã倩ç¶çã®æ§ã«HIVãæ ¹çµ¶ã§ããå¯èœæ§ãããïŒ
ãšèããŠããŸããŸãããã°ããŒããªã¹ããã°ããŒãã«è³æ¬äž»çŸ©ã®è¡ãéãã䟡å€èгãèãæ¹ã¯ä»¥äžã®æ§ãªæŠç¥ãæããŠããŸãã
察象åœéžå®ã®æ£ææ§ã«åžæ°ç€ŸäŒããæ¹å€
ã²ãŒã ãã§ã³ãžã£ãŒã®ç»å Ž
ã¬ãã«ããã«ã®æ§é åŒ
HIVäºé²ãæ²»çã®ãã²ãŒã ãã§ã³ãžã£ãŒããšèšãããã鷿广åæè¡ãã«åºã¥ãHIVäºé²ã»æ²»çè¬ã®éçºã¯ãç±³åœã®è£œè¬å€§æã®ãªã¢ãã»ãµã€ãšã³ã·ãºç€ŸïŒGilead SciencesïŒãšãç±³ãã¡ã€ã¶ãŒç€Ÿã»è±ã°ã©ã¯ãœã»ã¹ãã¹ã¯ã©ã€ã³ç€ŸïŒGSKïŒãHIVã«ç¹åããäŒæ¥ãšããŠèšç«ããååŒäŒæ¥ãŽã£ãŒãŽã»ãã«ã¹ã±ã¢ç€ŸïŒViiV HealthcareïŒããã®ããåã圢ã§é²ããããŠããããã®ãã¡ãã®ãªã¢ã瀟ã2022幎ã«éçºãããã¬ãã«ããã«ãã¯ããã«ãã·ãé»å®³å€ããšããæ°ããªã¿ã€ãã®HIVäºé²ã»æ²»çè¬ã§ãä»ã®HIVè¬ãšçµã¿åãããããšã§å幎ã«ïŒåã®æ³šå°ã§HIVã®åŒ·ãæå¶å¹æãæã€ã®ã¿ãªãããåæ§ã«å幎ã«ïŒåã®æ³šå°ã§HIVäºé²å¹æãæã€ãã€ãŸããHIVã¯ã¯ãã³ãååšããªãçŸåšãå幎ã«ïŒå泚å°ããã°ãHIVäºé²ãé²ããã¬ãã«ããã«ã¯ãæ°ããªãã¬ããïŒæé²åäºé²å æïŒè¬ãšããŠæŽ»çšããããšã«ãã£ãŠãåœéç®æšã§ããã2030幎ãŸã§ã®ïŒå°çèŠæš¡ã®å ¬è¡è¡çäžã®è åšãšããŠã®ïŒHIV/AIDSã®çµæ¯ããéæããããã®æå€§ã®ããŒã«ã®äžã€ãšèªèãããŠããã®ã§ããã
ïŒã€ã®ãžã§ããªãã¯äŒæ¥ã«çŽæ¥ã©ã€ã»ã³ã¹å¥çŽ
äžçã®HIVãžã®åãçµã¿ã®äž»èŠãªèå°ã¯ããµãã©ä»¥åã¢ããªã«ãã¯ãããšããã°ããŒãã«ãµãŠã¹è«žåœã§ãããã®ãªã¢ã瀟ã«ã¯ãæ°è¬ã§ããã¬ãã«ããã«ãããããã®åœã ã§ã©ã®ããã«ã¢ã¯ã»ã¹å¯èœã«ããããåãããŠãããããã«ã€ããŠã10æïŒæ¥ãã®ãªã¢ã瀟ã¯ããHIVã®åœ±é¿ã匷ããè³æºãéãããåœãïŒHigh incidence, Resource Limited CountriesïŒ120ãåœã察象ã«ãã¬ãã«ããã«ã«ã€ããŠãäžçã®ãžã§ããªãã¯è¬äŒæ¥ïŒç€Ÿãšèªçºçã©ã€ã»ã³ã¹å¥çŽãç· çµããããšãçºè¡šããããã®å¥çŽã¯ãã®ãªã¢ã瀟ãšãã¯ã¿ãŒã»ã¬ãã£ã»ã©ãã©ããªãŒãºïŒDr. Reddyâs Laboratoriesãã€ã³ãïŒããšã ãã¥ã¢ïŒEmcureãã€ã³ãïŒããšãŽã¡ã»ãã¡ãŒãïŒEva PharmaããšãžããïŒããã§ããœã³ãºã»ã©ãã©ããªãŒãºïŒFerozsons Laboratoriesãããã¹ã¿ã³ïŒããããïŒHeteroãã€ã³ãïŒããã€ã©ã³ïŒMylanãç±³åœïŒã®ïŒã€ã®ãžã§ããªãã¯äŒæ¥ãšã®éã§çŽæ¥ç· çµãããæ°è¬ã®ã©ã€ã»ã³ã¹å¥çŽã®ä»²ä»ãè¡ãªãåœéæ©é¢ã§ãããå»è¬åç¹èš±ããŒã«ãïŒMPPïŒã¯ä»åšããŠããªãã
ãå»è¬åç¹èš±ããŒã«ãã®æŽ»çšåé¿ã«æžå¿µ
åžæ°ç€ŸäŒã¯ã®ãªã¢ã瀟ã«å¯ŸããŠãã¬ãã«ããã«ã®ãžã§ããªãã¯äŒæ¥ãšã®ã©ã€ã»ã³ã¹å¥çŽã«ããã£ãŠã¯ãå ¬çæ©é¢ã§ããMPPãä»ããŠãéææ§ã»å ¬éæ§ããã³ç¶ç¶æ§ã確ä¿ãã¹ããšäž»åŒµããŠãããå®éãã®ãªã¢ã瀟ã¯ãããŸã§ã®HIVæ²»çè¬ã»äºé²è¬ã«ã€ããŠã¯ãMPPãä»ããŠã©ã€ã»ã³ã¹å¥çŽãè¡ã£ãŠããããå瀟ãéçºããCåèçãã³ããã®æ²»çè¬ã«é¢ããŠã¯ãMPPãä»ãããçŽæ¥ãžã§ããªãã¯äŒæ¥ãšã®ã©ã€ã»ã³ã¹å¥çŽãè¡ãªã£ãŠãããä»åã®ã¬ãã«ããã«ã«ã€ããŠããMPPãæŽ»çšããªãçŽæ¥å¥çŽã®åœ¢ããšã£ããããã«ã€ããŠã¯ãåžæ°ç€ŸäŒããæžå¿µã®å£°ãäžãã£ãŠãããéçºç³»è£œè¬äŒæ¥ãšãžã§ããªãã¯äŒæ¥ãšã®çŽæ¥ã®èªçºçã©ã€ã»ã³ã·ã³ã°ã¯ãäžç«çãªç¬¬äžè ãéããŠããªãåãæ å ±å ¬éã匱ããéææ§ã説æè²¬ä»»ã®ç¢ºä¿ãäžååãšãªãããŸããMPPåŽãã補è¬äŒæ¥ã«ã©ã€ã»ã³ã·ã³ã°ããŠãããããã«åŠ¥åãäœåãªããããæ¬æ¥MPPãæããã¹ã圹å²ãæãããªããªã£ãŠããŸãã
察象åœéžæã®æ£ææ§ã«æ¹å€
ãŸããã®ãªã¢ã瀟ãã¬ãã«ããã«ã®ãžã§ããªãã¯è¬ã®äŸçµŠãè¡ã察象ãšãã120ãåœã«ã€ããŠããåžæ°ç€ŸäŒããçæãšæžå¿µã衚æãããŠããããããåæãããšãåºæ¬ãïŒïŒïŒäœæåŸåœããã³äžäœäžæåŸåœã¯å¯Ÿè±¡ãïŒïŒïŒäžäœäžæåŸåœã«ã€ããŠã¯é察象ãšããããã ãïŒïŒïŒäžäœäžæåŸåœã®äžã§ãHIVææçã®é«ãå°åïŒã«ãªãæµ·ããµãã©ä»¥åã¢ããªã«çïŒã«ã€ããŠã¯å¯Ÿè±¡ãšããããšããååã§èšãã§ãããã®ãšèãããããããã§å€§èŠæš¡ã«é€å€ãããã®ããããŒã¿äžã¯ãäžäœäžæåŸåœããšãªã£ãŠãããã©ãžã«ããã«ãŒãã³ãã³ãã¢ãªã©äžå米諞åœã§ããããããã¯ã»ãŒäžäœäžæåŸåœã§ãããããããã®åœã ã§ã¯æè¿ãHIVææãå¢å ããŠãããPrEPãå«ãäºé²å¯Ÿçã®åŒ·åãå¿ èŠã§ãããšããã察象ããå€ãã®ã¯é©åœã§ã¯ãªããšã®å£°ãåºãŠãããå®éãåãäžå米諞åœã§äžäœäžæåŸåœã§ããã¬ã€ã¢ããšã¹ãªãã ã察象åœã«ãªã£ãŠãããããã¯ãHIVææçãçžå¯Ÿçã«é«ãã«ãªãæµ·å°åã®åœãšèªèãããããšã«ãããã®ã§ããããäžæ¹ãã¢ããªã«è«žåœã®äžã§ã¯ãäžäœã»äžäœäžæåŸåœã®å¢çç·äžã«ããã¢ã«ãžã§ãªã¢ãé€å€ãããäžæ¹ãäžäœäžæåŸåœã®ãªãã¢ã¯å ¥ã£ãŠããããã®ããã«ã察象ãšãªãåœã®éžæã«æ£ææ§ããããå®éã®ãšãããäŒæ¥å士ã®èªçºçã©ã€ã»ã³ã·ã³ã°ã«ãããŠã¯ãããããããšã«ã€ããŠèª¬æè²¬ä»»ãæããå¿ èŠããªãããšãåé¡ã§ããã
å é²åœã»æ¥æ¬ã§ã¯ã¬ãã«ããã«ã®ãã¬ãã䜿çšã¯ã»ãŒäžå¯èœ
ãªããã¬ãã«ããã«ã¯æ¥æ¬ã§ã¯ä»ã®æ²»çè¬ã«è¬å€èæ§ã®ãã人ã«éå®ããHIVæ²»çè¬ãšããŠã®ã¿èªå¯ãããŠãããè¬äŸ¡ã¯äžæ³šå°åœãã320äž8604åãšãªã£ãŠãããããã§ã¯åå€ããã¬ããã«äœ¿çšããããšã¯ã»ãŒäžå¯èœãšãããããã¬ããã«ã€ããŠã¯ãæ¥æ¬ã§ã¯è¿å¹ŽãŸã§èªå¯ãããè¬ã¯ãªãããžã§ããªãã¯è¬ã®åäººèŒžå ¥ãšãã圢ã§ããã«ããïŒã®ãªã¢ã瀟ã®ããããã« ãžãœãããã·ã« ããã«é žå¡©ãšãšã ããªã·ã¿ãã³ã®åå€ãšãã·ã³ãïŒããããã« ã¢ã©ãã§ããã ããã«é žå¡©ãšãšã ããªã·ã¿ãã³ã®åå€ïŒã䜿ãããŠããããããããã®ïŒæã«ãã«ããããã¬ããè¬ãšããŠã®èªå¯ãåãããæ¥æ¬ã«ããããã¬ããã®å ¬çèªç¥ãšããç¹ã§ã¯ãããã¯åé²ãšèšãããäžæ¹ãããã«ããããã«ããã«é¢ããŠã¯ããžã§ããªãã¯è¬ã®åäººèŒžå ¥ãã§ããªããªããã®ãªã¢ã瀟ã®è£œåãè³Œå ¥ããããšã«ãªããæ¥æ¬ã§ã¯ããã¬ããã¯äºé²è¬ã§ããããä¿éºé©çšã¯ãªããå ¬è¡è¡çã®èгç¹ããã®å©æå¶åºŠãä»ã®ãšããèšããããŠããªããããäŸ¡æ Œã¯äžé 2442åãäžãæã§ïŒäžåãè¶ ãããããŸã§ã®åäººèŒžå ¥ã«ããäŸ¡æ ŒïŒïŒäžåçšåºŠïŒãšæ¯èŒãããšïŒåçšåºŠã«äžæãããæ¥æ¬ã§ã®ãã¬ããè¬ã®æ¿èªã¯ãæ°ããªHIVäºé²æ¹æ³ã®å ¬çèªç¥ãšãã芳ç¹ããã¯åé²ãšèšããããããã«ããå®äŸ¡ãªãžã§ããªãã¯è¬ãžã®ã¢ã¯ã»ã¹ãå¶éããããã¬ãããžã®ã¢ã¯ã»ã¹ãçžåœé«é¡ã«ãªããšããç®èãªç¶æ³ãçãŸããŠããã
ãŸããã€ãŸããHIVãææçãå€ããè²§ããåœãåªå ããŠäœ¿çšããã®ã§ãå é²åœãªã©ã«ã¯åŸã«ãªããŸãããšãã話ã§ãã
ã»ã»ã»ã»
ãHIVãã¯ãããããªããªã®ãïŒ
åé¡ã®çºç«¯ã¯ç¿ãšäººã®æ§äº€æžã«ãããæ§ææçãã§ãã
ããã人ããäººã«ææããæ§ã«ãªã£ãã
ãæ§äº€æžã
æ§äº€æžã¯ãããããåå«ãæ®ããè¡çºã§ãã
ãæ§ææçãã®äºãèããæçŸå𿥿¬äººã¯ããæ¢ æ¯ããæ¥å¢åããŠããŸãã
åå ã¯
â ãåºäŒãç³»ãSNSã«ããæ§äº€æžã®ããŒãã«äœäž
â¡LGBTãç¹ã«ç·æ§åå£«ã®æ§äº€æž
â¢ãã«ã®ä¹±çš
ãšãªã£ãŠããŸãã
ã€ã¹ã©ã æã¹ã³ã掟ã®äººã ãããããèãããæ¥æ¬äººã¯è«å€ã®ç¥ãä¿¡ããªãäžæ¬ãªäººã ãªã®ãïŒ
æãã¯æ¥æ¬ã®ç¥éã¯äœãæããŠããã®ãïŒããã¯éªç¥ã§ã¯ãªããïŒ
ãšèšãããããªæ¥æ¬äººã®è¡åçµæã«ãªããŸãã
æ§äº€æžã¯ã©ã®å®æã«ãããŠã倧åãªããŒãã§ãã£ãã¯ãã§ãã
ç¹å¥ç§ã¯ã©ã®å®æã®è©ãæã€ã€ããããããŸãããã
ç®ã«èŠããªã倧åãªãã®ãå æãååšããŠããäºã¯æããŠããŸãã
話ã¯å ã«æ»ããŸããã
ãHIVããšãåå«ç¹æ ãã¯å¯æ¥ã«é¢ä¿ããŠãããã®ã§ãã
ã¢ã¡ãªã«ã§ã倧統é éžã§ã人å£äžçµ¶ã«ã€ããŠå€§ããªè°è«ã«ãªããŸããã
åã¯æ¥æ¬äººã¯èªåéãèŠãŠããªãæ°æãäœãä¿¡ããŠçããŠãã人ã ããäžåºŠäŸ¡å€èгãå ±æããŠäžäººã²ãšãããããããã®äººçã§äœãéžæããŠããã®ããå¿ èŠãªã®ã ãããšæããŸãã
ç§»æ°åé¡ãšã¯å¥ã§ããã
ãããããæ§äº€æžãã®æ¬è³ªãå
±æãããŠããããšããæãäºé²ç·ã«ãªãããšæããŸãã
ãåå«ç¹æ ãã®çºã«å
šãŠã®åºä¹³é¡ãç¥å
ãããã£ãšè¡ã£ãŠããããšã§ããã
ãã®å æã®å
ã«èªåãååšããŠããããããŠããããã®ãåå«ããçã¿åºããŠããè¡çºã§ããããšã
æ¯å¹Žå€§éã«è¡ãããŠããã人å£äžçµ¶ã®åé¡ããŸãã
æ¥æ¬åœãšåœæ°ãæªããŠãããèŠå ã®äžã€ã§ãããšæããŸãã
å šãŠãåããæªãããçœããé»ãããåã¡ããè² ããã®æ§ãªçŠç¹ãçµã£ã2å ã§èããããšã¯ä¹±æŽã§ãããæ¬è³ªããéžè±ããã
ãããäºçްãªåžžèç倿ãããæèãæ³šèŠããŠã倿§ãªå¯èœæ§ãã倿ãéžæããå¿ èŠæ§ãåžžã«äººçã®äžã§ãå°ããªåºæ¥äºã®äžã§ããã éããŠããå¿ èŠæ§ãããã®ã ãšæããŸãã
ãã®æå³ã§ãã人å£äžçµ¶ããšããè¡çºã«ã€ããŠããèªç¶åŠåš ã«ã€ããŠã
ãã¬ã€ãã®æ§ãªç¯çœªæ§è¡çºããšãäž»äœçæå¿ã«ããæ§è¡çºããæ··åããŠãããšèšããŸãããïŒ
ãŸãããã«é¢ããŠã倿§ãªå®¢èгçå€æãæ±ããããŠãããšæããŸãã
ãã¥ãã«ããŠãã人å£äžçµ¶ã倿ããã®ã¯ã女æ§ãã§ããã女æ§ããçåœãç¥å ãåå«ãã«å¯ŸããŠã©ããªãå¿ãšæèãã§åãåã£ãŠçããã®ãïŒã«ããã£ãŠããŸãã
倧åãªäºã¯ãäºãã®æ§ã®éãã®å°éã§ãããåœããåã®éããåœããåã«æããŠçããäºãªã®ã ãšæããŸãã
ã°ããŒããªãºã ãšãããååŽè¥¿æ¬§äž»å°ã§é²ãã§ããå°ç人é¡ã¯äžäœã©ãã«åããã®ã§ããããïŒ
ãéžæçèªæ»ãã«å¯ŸããŠã¯æ¿ããå察ãããã®ã«ããéžæçæ®ºäººããšåŒã°ããã人å£äžçµ¶ãã¯å¯èœã§ããã
ããããæãéããŠç€ŸäŒã®äžã«èå»¶ãã空æ°ã¯ãçµ¶æã«ã¯ãªããªãã§ããããïŒ
ç§ã¯ç·æ§ãªã®ã§ã女æ§ã®èº«äœãæèŠã¯æ¬åœã®æå³ã§ã¯ããããŸãããã人å£äžçµ¶ãããšãã«äœãæããªããšããäºã¯ãªãã¯ãã§ãã
ãå°åå察çã
æ¥æ¬åœã¯æªæ¥ãžæ°æå亡ã®å±æ©ã«ãããŸããã
æ¬åœã®æå³ã§ã®å°åå察çã¯ã
ãçåœãã®ãã®ãšããŠã®èªåéäžäººäžäººã®ååšãšãæ¥ã ã®è¡çºãèŠã€ããã
ãã¹ã¡ãã£ã¢ãæè²ãæ¿æ²»ã瀟äŒã«åœ±é¿ãäžãã人ã ããããåœããåã®æ§ã«èªããç©ºæ°æãçãŸããŠè¡ããªãéããããããå ãå é床çã«æ¥æ¬ã¯ãå¿ããã°ããŒããªãºã æã®äœã£ãåžžèç倿ãšãç¡æèã«ãããªã£ãŠèªåã®å¿ã殺ããŠããåæ³è¡çºãåå ã§ãèªåéã§èªåéãæžãããŠäº¡åœãšãªãå¯èœæ§ãé«ããšæããŸãã
å°ç人é¡ã¯æèããããŸãããçç©ã§ããããŸãã
人工ç¥èœã人é¡ã®ç¥æ§ãäžåãæä»£ã
æã ã¯äžäººã²ãšããåºä¹³é¡ã§ããããšãé¡äººç¿ãšããŠçãæ®ã£ãå¯äžã®ååšã§ããããšããæèãããšãããããæªæ¥ã®åšãæ¹ãèŠã€ããŠã¿ãŸãããïŒ
ãã®æ å ±ã®æãæ¹ãæ å ±ã®éžææ¬¡ç¬¬ã§å³åŸå·ŠåŸãããããŠçããããšããèªã倿ããŠæªæ¥ç€ŸäŒãžå æãäœãåºãããšãå¯èœã§ãã
éåãã€ãã®èšŒæã¯ãããããã®æèããã®å®å®å šãŠãåãããŠããå¯èœæ§ãã瀺åããŠããŸãã
çæ³ãç¥ãããã®ä»äººé¡ã«éããå šãŠã®çåœãè¡ãªã£ãŠããããããè¡åãå®å®å æãäœãåºããŠããããããããè³ã«ããæèãè¡ããå°ççåœã«ãããŠæãæèèœåãçºéãã人é¡ã«ãããã®ãå®å®æå€§ã®å æã ã£ããšãããªãã°ã
å šãŠã¯ä»ãçãããæã å šãŠãããªãæ¹å šãŠã®ååšã«ããéåãã€ããåŒãèµ·ãããŠããäžçãªã®ãããããŸããã
ã§ã¯ãŸãã
- #SNS
- #ãªãŒã«ãã¡ãã£ã¢
- #HIV
- #èªç¶åŠåš
- #ãžã§ããªãã¯
- #æ§ææç
- #æ¢ æ¯
- #ç°æ¬¡å ã®å°åå察ç
- #ç¹å¹è¬
- #人å£åæžèšç»
- #çåœã®ç¥ç§
- #ããããè«
- #éèè³æ¬äž»çŸ©
- #ãã¥ãŒã¡ãã£ã¢
- #ã¬ãã«ããã«
- #人å£äžçµ¶
- #æ°æå亡ã®å±æ©
- #ã°ããŒããªãºã ã«æ» ãŒããã
- #ã¢ã¡ãªã«åè¡åœå€§éžæ
- #å®æãšæ§è¡çº